REATA PHARMACEUTICALS INC-A (RETA)

US75615P1030 - Common Stock

172.36  +0.04 (+0.02%)

After market: 172.4 +0.04 (+0.02%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
23.48M2.22M11.49M9.02M26.52M
Cost Of Goods
N/AN/A0.00N/A124.40M
Gross Profit
N/AN/A11.49MN/A-97.88M
Operating Expenses
364.30M280.25M256.20M235.34M187.34M
Research and Development
203.31M169.84M155.99M159.08M128.11M
Selling, General, and Administrative Expenses
159.87M109.28M99.00M75.13M58.30M
Operating Income
-341.67M-278.03M-244.71M-226.33M-285.22M
Interest Income/Expense
11.19M5.99M-6.39M-12.13M-4.95M
Other Income/Expense
-37.58M-41.98M-46.74M-21.89M10.00K
Non Recurring Items
N/A2.10M0.00-9.90M0.00
Income Before Taxes
-87.68M-311.93M-297.84M-270.24M-290.16M
Income Tax
-55.00K-25.00K-450.00K-290.00K10.00K
Net Income
-87.62M-311.90M-297.39M-247.75M-290.17M
EBITDA
-340.54M-276.90M-243.50M-225.19M-284.29M
 
Per Share Data
EPS Diluted Total Ops
-2.99-8.54-8.19-7.34-9.54
Non GAAP EPS
-2.98-8.54-8.18-6.98-5.03
 
Statistics
Gross Profit Margin
N/AN/A100.00%N/A-369.08%
Profit Margin
-373.17%-14074.95%-2588.22%-2746.67%-1094.16%
Operating Profit Margin
-1455.08%-12546.66%-2129.75%-2509.20%-1075.49%

All data in USD

Charts